primary dysmenorrhea
Conditions
Sponsors
The First Affiliated Hospital ,University of South China
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of primary dysmenorrhea (2) Age ranged from 14 to 35 years old. (3) Basic rules of the menstrual cycle (28 ±, 7 days). (4) Designers who volunteered to participate in the clinical study signed an informed consent, did not have other treatment for dysmenorrhea within 1 month before the acupuncture treatment, and did not take NSAoidal anti-inflammatory drugs and painkillers within the first 2 weeks of the electric needle. (5) Willing to cooperate with the treatment operation, examination and efficacy evaluation, and did not participate in other clinical experiments. (6) Average pain visual simulation score (VisualAnalogueScale, VAS) for 4cm. (7) Sign the informed consent form. The above 7 simultaneous applicants can only be included in the test.
Exclusion criteria
Exclusion criteria: (1) After examination, western medicine is diagnosed as a secondary dysmenorrhea caused by uterine fibroids, adenomysiosis, endometriosis, pelvic inflammation, internal foreign body, ovarian lesions and other organic lesions. (2) Menstrual period is successively irregular. (3) Patients with serious cardiovascular and cerebrovascular diseases, serious diabetes mellitus, serious infection, liver and renal insufficiency, hematopoietic diseases, AIDS, and tuberculosis, hepatitis and other infectious diseases. (4) People with obvious mental illness and obvious cognitive dysfunction. (5) Pregnancy or pregnancy, lactation and postpartum within 1 year. (6) Those who are participating in other clinical trials. Note: Studies were excluded for any one of the above compliance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differance between Digital P 2 (The Numeric Pain Rating Scale Instructions, NIRS) in weeks 12 and 24.;VAS score before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Week 12 and 24 (CMSS);safety evaluation;Self-rated anxiety scales and self-rated depression scales at weeks 12 and 24;Blood and urinary metabolomics were tested before treatment and for 12 weeks of treatment.;Evaluation of patient acupuncture expectations;COX dysmenorrhea symptom scale at weeks 12 and 24; | — |
Countries
China
Contacts
Public ContactLiuXin
Outcome results
None listed